Keywords: ضد انعقاد خوراکی; Venous thromboembolism; Oral anticoagulation; Percutaneous coronary intervention; Stent;
مقالات ISI ضد انعقاد خوراکی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد انعقاد خوراکی; Bleeding; Brain lesion; Brain magnetic resonance imaging; Left atrial appendage closure; Oral anticoagulation; Silent cerebral lesion;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulation; Chronic kidney disease; Coronary intervention; Valvular heart disease;
Keywords: ضد انعقاد خوراکی; Left atrial appendage; Atrial fibrillation; Thromboembolism; WATCHMAN; Oral anticoagulation; Amulet;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Left atrial appendage closure; Oral anticoagulation; Stroke prevention; Watchman;
Keywords: ضد انعقاد خوراکی; BRS; bioresorbable scaffold; DAPT; dual antiplatelet therapy; MACE; major adverse cardiac event; ST; stent or scaffold thrombosis; TAT; triple antithrombotic therapy; TLF; target lesion failure; TLR; target lesion revascularization; TVF; target vessel fai
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Temporary suspension; Invasive procedure; Anticoagulación oral; Suspensión temporal; Procedimiento invasivo;
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; CIAP-2-E; International Classification of Primary Care-2-E; CIE-9-MC; International Classification of Diseases, ninth revision, Clinical Modification; AHT; arterial hypertension; OA; oral anticoagulation; SIAC; information system
Keywords: ضد انعقاد خوراکی; Anticoagulación oral; Suspensión temporal; Procedimiento invasivo; Oral anticoagulation; Temporary suspension; Invasive procedure;
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Warfarin; Percutaneous coronary intervention; Stent;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulation; Outcomes; Quality of care;
Keywords: ضد انعقاد خوراکی; Percutaneous coronary intervention; Acute coronary syndromes; Oral anticoagulation; Parenteral anticoagulation; Oral antiplatelet therapy; Parenteral antiplatelet therapy;
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; ATT; antithrombotic treatment; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65-74 years, female sex category; EORP-AF; EURObse
Keywords: ضد انعقاد خوراکی; 4-dimensional computed tomography; heart valve prosthesis; surgical aortic valve replacement; thromboembolism; thrombolytic therapy; transcatheter aortic valve replacement; 4D; 4-dimensional; ACT; activated clotting time; AF; atrial fibrillation; BPV; bio
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Stroke; Coronary artery disease; Acute coronary syndrome; Percutaneous coronary intervention; Stenting; Oral anticoagulation; Antiplatelet therapy;
Keywords: ضد انعقاد خوراکی; AHA; American heart association; AF; atrial fibrillation; ACS; Acute coronary syndrome; B; Bayesian; CENTRAL; Cochrane Central Register of Controlled Clinical Trials; C; Clopidogrel; CV; Cardiovascular; CrI; Credible Interval; CI; Confidence interval; DAP
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulation; Warfarin utilization; Embolic stroke;
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Atrial fibrillation; Renal embolism; Acute renal infarction; Acute renal failureAnticoagulación oral; Fibrilación auricular; Embolia renal; Infarto renal agudo; Insuficiencia renal aguda
Keywords: ضد انعقاد خوراکی; atrial fibrillation; edoxaban; net clinical benefit; oral anticoagulation; warfarinAF, atrial fibrillation; CHA2DS2-VASc, congestive heart failure, hypertension, age 65 to 74 or ≥75 years, diabetes, stroke or transient ischemic attack, vascular disease, s
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Atrial fibrillation; Percutaneous coronary intervention; Bridging anticoagulation; Heparin; Meta-analysis;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Death; Heart failure; Oral anticoagulation; Stroke;
Keywords: ضد انعقاد خوراکی; AAD; antiarrhythmic drug; ACEi; angiotensin-converting enzyme inhibitor; AF; atrial fibrillation; AFFIRM; Atrial Fibrillation Follow-up Investigation of Rhythm Management; ARB; angiotensin receptor blocker; ARIC; Analysis of the Atherosclerosis Risk in Co
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Inpatient mortality; Oral anticoagulation; Sex;
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; ischemic stroke; oral anticoagulation; adherence
Keywords: ضد انعقاد خوراکی; Fibrilación auricular; Anticoagulación oral; Nuevos anticoagulantes orales; Ingreso hospitalarioAtrial fibrillation; Oral anticoagulation; Novel anticoagulant agents; Hospitalization
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulation; Novel anticoagulant agents; HospitalizationFibrilación auricular; Anticoagulación oral; Nuevos anticoagulantes orales; Ingreso hospitalario
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; CHADS2; Congestive heart failure, hypertension, age â¥75 years, diabetes and stroke; CHA2DS2-VASc; Congestive heart failure, hypertension, age â¥75 years, diabetes, stroke, vascular disease, age â¥65 years and sex category; cLA
Keywords: ضد انعقاد خوراکی; Elderly; Trauma; Falls; Oral anticoagulation
Keywords: ضد انعقاد خوراکی; angioplasty; oral anticoagulation; primary percutaneous intervention; ST-segment elevation myocardial infarction; CI; confidence interval; DAPT; dual-antiplatelet therapy; INR; international normalized ratio; LV; left ventricular; NACE; net adverse clinic
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; AHRE; atrial high rate episode; CIED; cardiac implantable electronic device; ECG; electrocardiogram; HR; hazard ratio; ICD; implantable cardioverter-defibrillator; ICM; insertable cardiac monitor; MCOT; mobile cardiac outpatient t
Keywords: ضد انعقاد خوراکی; atrial fibrillation; cardioembolic stroke; Lariat device; left atrial appendage; suture ligation; AF; atrial fibrillation; ASA; aspirin; CT; computed tomography; LAA; left atrial appendage; OAC; oral anticoagulation; RV; right ventricle; TEE; transesopha
Keywords: ضد انعقاد خوراکی; Dialysis; end-stage renal disease (ESRD); hemodialysis; atrial fibrillation (AF); cardiac arrhythmia; warfarin; oral anticoagulation; drug safety; ischemic stroke; hemorrhagic stroke; bleeding; prevention; mortality;
Keywords: ضد انعقاد خوراکی; ACT; activated clotting time; AF; atrial fibrillation; CB; cryoballoon; CB-A; cryoballoon ablation Arctic Front Advance; CT; computed tomography; ECG; electrocardiography; LA; left atrium; LIPV; left inferior pulmonary vein; LMWH; low-molecular-weight hep
Keywords: ضد انعقاد خوراکی; Acute ischemic stroke; atrial fibrillation; kidney disease; renal dysfunction; oral anticoagulation; direct oral anticoagulants;
Keywords: ضد انعقاد خوراکی; ACP; Amplatzer cardiac plug; AF; atrial fibrillation; ESC; European Society of Cardiology; INR; international normalized ratio; LA; left atrium; LAA; left atrial appendage; LAAC; left atrial appendage closure; OAC; oral anticoagulation; TEE; transesophage
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Anticoagulation quality; VKA; Causes of poor anticoagulation quality
Keywords: ضد انعقاد خوراکی; Intracerebral hemorrhage; Warfarin; Oral anticoagulation; New oral anticoagulants;
Keywords: ضد انعقاد خوراکی; acenocoumarol; clopidogrel; dual antiplatelet therapy; oral anticoagulation; phenprocoumon; platelet aggregationACS, acute coronary syndrome(s); AF, atrial fibrillation; BARC, Bleeding Academic Research Consortium; DAPT, dual antiplatelet therapy; LMWH, l
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; ATRIA; Anticoagulation and Risk Factors in Atrial Fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart failure, hyperte
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Prothrombin complex concentrates; Direct thrombin inhibitors; Xa antagonists; Platelets;
Keywords: ضد انعقاد خوراکی; PCI; percutaneous coronary intervention; OAC; oral anticoagulation; AF; atrial fibrillation; INR; international normalized ratio; UFH; unfractionated heparin; ACT; activated clotting time; BARC; Bleeding Academic Research Consortium; TIMI; Thrombolysis in
Keywords: ضد انعقاد خوراکی; AF; atrial fibrillation; cW; continuous warfarin; dOAC; discontinued warfarin; LA; left atrium; NOAC; new oral anticoagulants; OAC; oral anticoagulation; RF; radiofrequency; VKA; vitamin K antagonists; Atrial fibrillation; Catheter ablation; Heparin; Oral
Keywords: ضد انعقاد خوراکی; ACP; Amplatzer Cardiac Plug; AF; atrial fibrillation; ASA; aspirin; DPI; dual platelet inhibition; LA; left atrium/atrial; LAA; left atrial appendage; NVAF; nonvalvular atrial fibrillation; OAC; oral anticoagulation; PROTECT-AF; Percutaneous Closure of th
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; ischemic stroke; secondary prevention; hemorrhagic transformation; DOAC; atrial fibrillation
Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulation; Aspirin; Time in therapeutic range; Major adverse outcomes;
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Percutaneous coronary intervention; Oral anticoagulation;
Influence of vitamin K antagonists and direct oral anticoagulation on coronary artery disease: A CTA analysis
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Oral anticoagulation; Coronary artery disease; Computed tomography; Atherosclerosis;
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
Keywords: ضد انعقاد خوراکی; Oral anticoagulation; Time in therapeutic range; Atrial fibrillation; Stroke;
Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review
Keywords: ضد انعقاد خوراکی; Atrial fibrillation; Decision making; Oral anticoagulation; SAMe-TT2R2 score; Venous thromboembolism; Vitamin K antagonist;
Adecuación del tratamiento antitrombótico en los pacientes con fibrilación auricular no valvular. Registro AFINVA
Keywords: ضد انعقاد خوراکی; Tratamiento antitrombótico; Anticoagulación oral; Fibrilación auricular no valvular; Registro AFINVA; Antithrombotic treatment; Oral anticoagulation; Non-valvular atrial fibrillation; AFINVA register;